Azitra, Inc. Current Liabilities
Azitra, Inc. (AZTR) had Current Liabilities of $1.53 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $1.53M.
- 2026-03-31: Liabilities, Current $1.55M.
- 2025-12-31: Liabilities, Current $1.07M.
- 2025-09-30: Liabilities, Current $1.81M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $1.53M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.55M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $1.07M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $1.81M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.45M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $1.28M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.38M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.37M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.74M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.26M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.60M 10-K · filed 2025-02-24 |
| 2023-09-30 | $1.45M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.74M 10-Q · filed 2023-08-14 |
| 2022-12-31 | $2.22M 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |